Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Vopr Onkol ; 52(4): 427-32, 2006.
Article in Russian | MEDLINE | ID: mdl-17024816

ABSTRACT

The investigation deals with an assessment of carcinogenicity and mutagenicity of samples of smokeless tobacco now on the Russian market as well as ash from alternative cigarettes made of aromatic herbs. Our data showed that the levels of polycyclic aromatic hydrocarbons, volatile and tobacco-specific N-nitrosoamines complied with the standards in the producer-countries. Smokeless tobacco extracts failed to show (Ames) any mutagenic effects such as the "read-out frame shift" or "base-pair replacement" patterns. No tobacco-specific N-nitrosoamines were identified in herbal cigarettes. However, polycyclic aromatic hydrocarbons and volatile N-nitrosoamines content appeared to be identical to that of tobacco. Herbal cigarette smoke extracts mutagenicity induced by side-effects of carcinogenic substances was of similar magnitude as well.


Subject(s)
Carcinogens/isolation & purification , Nitrosamines/isolation & purification , Plants, Toxic/adverse effects , Polycyclic Aromatic Hydrocarbons/isolation & purification , Tobacco, Smokeless/adverse effects , Humans , Mutagenicity Tests
2.
Eur J Cancer Prev ; 2(1): 61-8, 1993 Jan.
Article in English | MEDLINE | ID: mdl-8428179

ABSTRACT

Increase of ornithine decarboxylase (ODC) activity is known to be associated with cell proliferation and, very likely, with tumour promotion. This prompted us to study the activity of ODC in gastric mucosa of patients with chronic atrophic gastritis that has been considered as a precursor of stomach cancer. Examination of 124 patients with this disease revealed the considerable increase in ODC activity in atrophic mucosa (29.8 +/- 2.9 vs 7.9 +/- 1.8 units in normal mucosa, p = 0.001). Supplementation of the patient's diet with beta-carotene (20 mg daily during 3 weeks) results in a statistically significant decrease in ODC activity in gastric mucosa. The data obtained confirm the possibility of application of ODC determination to the detection of early premalignant lesions and suggest the antipromoter activity of beta-carotene in gastric carcinogenesis.


Subject(s)
Carotenoids/administration & dosage , Gastric Mucosa/enzymology , Gastritis, Atrophic/enzymology , Ornithine Decarboxylase/metabolism , Adult , Aged , Aged, 80 and over , Female , Gastric Mucosa/drug effects , Gastritis, Atrophic/drug therapy , Humans , Male , Middle Aged , Ornithine Decarboxylase/drug effects
3.
Vopr Med Khim ; 38(6): 33-6, 1992.
Article in Russian | MEDLINE | ID: mdl-1298126

ABSTRACT

Activity of ornithine decarboxylase was significantly increased, reaching the maximal values in malignant gastric tissues, in mucosal membrane and polypous tissue of patients with atrophic gastritis as compared with normalcy. Any alterations in the enzymatic activity were not observed in the gastric mucosal membrane of 19 patients with atrophic gastritis within 3 weeks. At the same time, statistically significant decrease of the abnormal high activity of ornithine decarboxylase was detected in atrophic gastric mucosal membrane of 12 patients among 20 patients examined, which were treated with 20 mg of beta-carotene daily within 3 weeks; the enzyme activity was decreased also in polypous tissue of 5 patients in the group of 9 patients studied. Decrease in the ornithine decarboxylase activity after beta-carotene treatment involved improvement of the mucosal membrane state, where hemorrhage disappeared and inflammation reduced. Since the high activity of ornithine decarboxylase is related to promotion of cancerogenesis, beta-carotene appears to exhibit an anticarcinogenic effect as it decreases the enzymatic activity in gastric mucosal membrane.


Subject(s)
Carotenoids/pharmacology , Gastric Mucosa/enzymology , Ornithine Decarboxylase/metabolism , Polyps/enzymology , Stomach/pathology , Adult , Aged , Female , Gastritis, Atrophic/enzymology , Humans , Male , Middle Aged , Ornithine Decarboxylase Inhibitors , beta Carotene
SELECTION OF CITATIONS
SEARCH DETAIL
...